Restoring gut microbial ecology
BiomeBank (biomebank.com) earns a Brand Analyzer score of 70 out of 100, placing it in the Developing tier among Healthcare brands, Technology brands. Among 2305 Healthcare brands analyzed, BiomeBank ranks in the 62nd percentile (category average 68, leader 95). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 93/100, Digital Presence 76/100, Visual Identity 93/100, Messaging Clarity 100/100, Trust Foundation 66/100, AI Discoverability 77/100, Brand Authority 20/100.
BiomeBank is a clinical-stage biotechnology company focused on microbiome restoration. Its mission is to treat the microbiome and prevent disease by restoring gut microbial ecology. The company develops next-generation probiotics and therapeutics using regulated donor-derived materials. BiomeBank has established strategic partnerships, including one with Blackmores, to expand into global markets. It positions itself at the intersection of preventive medicine and microbiome science, targeting healthcare professionals, patients, and biotech investors.
| Brand Name | BiomeBank |
|---|---|
| Domain | biomebank.com |
| Industry | Healthcare, Technology |
| Main Competitors | Seres Therapeutics, Finch Therapeutics, Vedanta Biosciences, Pendulum Therapeutics, Rebiotix, Ferring Pharmaceuticals |
Moz Domain Authority 30/100 vs category average 29 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "BiomeBank is a clinical stage biotechnology company with a mission to treat our microbiome and prevent disease by restoring gut microbial ecology." (Meta description: 22 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, Product/Article schema, + Microdata, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Social footprint: verified profiles on LinkedIn, YouTube, Instagram; no detected presence on X (Twitter), Facebook, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
BiomeBank scores 24/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
BiomeBank has a weak AI-visibility profile at 24/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is trust (43/100) and its weakest is visibility (0/100). It benefits from open access for AI crawlers (GPTBot, ClaudeBot, etc.) and machine-readable schema.org markup. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, no strong Wikidata entry and a low Moz Domain Authority of 30/100.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
BiomeBank's main competitors include Seres Therapeutics, Finch Therapeutics, Vedanta Biosciences, Pendulum Therapeutics, Rebiotix. These companies compete in the Healthcare space for similar customers, offering comparable products or services.
Sources: BiomeBank official site
Popular alternatives to BiomeBank include Seres Therapeutics, Finch Therapeutics, Vedanta Biosciences, Pendulum Therapeutics, Rebiotix. Each is an established option in the Healthcare space; the best fit depends on your specific needs, budget, and required features.
Sources: BiomeBank official site
BiomeBank is a clinical-stage biotechnology company with a mission to treat the microbiome and prevent disease by restoring gut microbial ecology. It operates at the intersection of preventive medicine and microbiome science, developing regulated therapeutics and next-generation probiotics. The company targets healthcare professionals, patients with microbiome-related conditions, and biotech investors, and has pursued strategic partnerships to expand its global reach.
Sources: BiomeBank official site
BiomeBank has low AI-search visibility, scoring 24/100 on Brand Analyzer's AI visibility composite (visibility 0, trust 43, recommendation 43). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: BiomeBank official site
BiomeBank develops next-generation probiotics and microbiome therapeutics using regulated donor-derived materials to restore gut health. Its work is aimed at treating microbiome-related conditions and preventing disease through the restoration of gut microbial ecology. The company also pursues strategic partnerships - such as its collaboration with Blackmores - to enable global market expansion of its products and technologies.
Sources: BiomeBank official site
BiomeBank offers next-generation probiotics and microbiome therapeutics developed using regulated donor-derived materials. These products are designed to restore gut microbial ecology and treat microbiome-related conditions. The company operates in the clinical-stage space, meaning its products are in development and/or undergoing clinical evaluation rather than being widely available as consumer products.
Sources: BiomeBank official site
BiomeBank and Seres Therapeutics are competitors in Healthcare. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Sources: BiomeBank official site
BiomeBank scores 43/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: BiomeBank official site
BiomeBank can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: BiomeBank official site
According to the available information, BiomeBank's target audience includes healthcare professionals seeking microbiome-based therapeutic solutions, patients with microbiome-related conditions who may benefit from gut health restoration, and investors in the biotechnology sector. The company's partnership with Blackmores also suggests potential reach into broader consumer health markets globally.
Sources: BiomeBank official site
BiomeBank is known for pioneering microbiome restoration as a clinical approach to preventive medicine. It is recognized for developing next-generation probiotics and therapeutics using regulated donor-derived materials, and for its strategic partnership with Blackmores aimed at global market expansion. The company positions itself as a leader in clinical-stage microbiome biotechnology.
Sources: BiomeBank official site
Ranked closest to BiomeBank: BioCircuit Technologies (70/100), Bigfoot Biomedical (70/100), BIOSerenity (70/100), Bitwerx, Inc. (70/100).
A step up - brands to learn from: Zipari by mPulse (71/100), Zaina AI (71/100).
Category leader: Dassault Systèmes (95/100).